Delin Ventures

Delin Ventures is a mission-driven venture capital firm based in the United Kingdom, focusing on early-stage technology companies. The firm operates two primary funds: the Life Sciences Fund and the Technology Fund. The Life Sciences Fund invests in cell therapy companies, aiming to improve human lives through innovative therapeutic concepts and scalable manufacturing solutions. The Technology Fund supports founders working on advancements in the future of work and learning, providing straightforward investments and comprehensive support to help partners achieve peak performance. Delin Ventures differentiates itself through a hands-on approach, offering operational expertise, personal coaching, and access to a global network of experts and investors. The firm is committed to long-term impact, providing patient capital to support the sustained success of its portfolio companies. With a team of deep domain experts in various areas of life sciences and technology, Delin Ventures enhances the chances of its partners winning in their respective markets.

Delin Ventures has made 27 investments, with its most recent on May 14, 2025, in Penzilla. The firm has raised a single venture fund, the Future of Work & Learning Fund, announced on January 17, 2024. Notable exits include Cazoo, import.io, and Lingumi. The firm's portfolio spans various industries, including life sciences, technology, healthcare, education, human resources, productivity, media, entertainment, consumer goods, fintech, edtech, healthtech, biotechnology, pharmaceuticals, and medical devices.

For startups interested in seeking funding, Delin Ventures encourages entrepreneurs to provide a concise overview of their business, including the problem they are solving, their unique value proposition, and any traction they have achieved. The team reviews all submissions and will reach out for further discussions if there is a potential fit.